Key result
Isolated ischemic heart disease is linked to ~51% higher risk of severe maternal morbidity or death.
Why the study?
The impact of pre-existing ischemic heart disease on pregnancy outcomes during delivery hospitalizations is incompletely described.
Does pre-existing isolated ischemic heart disease increase the risk of severe maternal morbidity or death during delivery hospitalizations compared to patients without cardiac disease?
Cohort (n=11,556,136)
Yes
Does pre-existing isolated ischemic heart disease increase the risk of severe maternal morbidity or death during delivery hospitalizations compared to patients without cardiac disease?
Isolated ischemic heart disease in pregnancy is associated with a significantly increased risk of severe maternal morbidity or death during delivery, approximating the risk seen in WHO class I-II cardiac diagnoses.
May warrant closer peripartum monitoring in ischemic heart disease; leaves open whether targeted strategies reduce maternal morbidity.
BACKGROUND: The impact of pre-existing ischemic heart disease (IHD) on pregnancy is incompletely described. OBJECTIVES: The purpose of this study was to compare adverse pregnancy outcomes between those with IHD and those with a cardiac diagnosis categorized by the modified World Health Organization classification and those without a cardiac diagnosis. METHODS: This retrospective study used the 2015 to 2018 Nationwide Readmissions Database. Delivery hospitalizations, comorbidities, and outcomes were identified using diagnosis and procedure codes. The exposure was isolated IHD. The primary outcome was severe maternal morbidity (SMM) or death during the delivery hospitalization, analyzed using adjusted relative risk (aRR) regression and weighted to account for the Nationwide Readmissions Database's complex survey methods. RESULTS: Of 11,556,136 delivery hospitalizations, 65,331 had another cardiac diagnosis, and 3,009 had IHD alone. Patients with IHD were older and had higher rates of diabetes and hypertension. In unadjusted analyses, adverse outcomes were more common among patients with IHD alone than among patients with no cardiac disease and modified World Health Organization class I-II disease. After adjustment, patients with IHD alone were associated with a higher risk of SMM or death (aRR: 1.51; 95% CI: 1.19-1.92) than those without a cardiac disease. In comparison, the aRR was 1.90 (95% CI: 1.76-2.06) for WHO class I-II diseases and 5.87 (95% CI: 5.49-6.27) for WHO II/III-IV diseases. Nontransfusion SMM or death (aRR: 1.60; 95% CI: 1.11-2.30) and cardiac SMM or death (aRR: 2.98; 95% CI: 1.75-5.08) were also higher for those with IHD. CONCLUSIONS: Isolated IHD in pregnancy is associated with worse outcomes than no cardiac disease during delivery hospitalization and approximates the risk associated with WHO I-II diagnoses.
No takes yet. Share an insight, caveat, or question.
Denoble et al. (2022) conducted a cohort in Pregnancy / Delivery hospitalizations (n=11,556,136). Isolated ischemic heart disease vs. No cardiac disease was evaluated on Severe maternal morbidity (SMM) or death during the delivery hospitalization (aRR 1.51, 95% CI 1.19-1.92). Isolated ischemic heart disease during delivery hospitalizations was associated with a higher risk of severe maternal morbidity or death compared to no cardiac disease (aRR 1.51; 95% CI 1.19-1.92).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: